We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Throughput System for DNA Sequencing

By Biotechdaily staff writers
Posted on 25 Oct 2005
A novel high-throughput system will enable researchers to sequence genomes and long DNA sequences up to 100 times faster than current commercial platforms.

The Genome Sequencer 20 system is based on a nanotechnology-based approach to sequencing, invented by 454 Life Sciences (Branford, CT, USA). More...
The company is manufacturing the system and reagent kits for Roche Diagnostics (Basel, Switzerland), which is distributing the system and reagents to all markets except regulated diagnostics.

The Genome Sequencer 20 represents the first commercially available instrument to provide a convenient solution for ultra-high-throughput DNA sequencing. Following a single step to prepare an entire genome, the compact system can sequence as least 20 million bases in one five-hour run. The technology eliminates the need for large-scale robotics as it is used in established techniques. A researcher can prepare, sequence, and generate results in days instead of months. The technology performs massively parallel sequencing on a PicoTiterPlate, employing state-of-the-art image processing, and utilizes data analysis to achieve high-quality results.

"The Genome Sequencer 20 System provides a new and promising foundation for research applications,” noted Heino von Prondzynski, CEO, Roche Diagnostics. "We are excited to be able to enter this market and offer the latest innovative technology to researchers around the world.”





Related Links:
454 Life Sciences
Roche Diagnostics

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Manual Pipetting Aid
Pipette Controllers macro
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.